Yahoo
KSE - Delayed Quote KRW

Chong Kun Dang Holdings Corp. (001630.KS)

35,250.00 +200.00 (+0.57%)
At close: 3:30:30 PM GMT+9
Chart Range Bar
Loading chart for 001630.KS
  • Previous Close 35,050.00
  • Open 35,150.00
  • Bid 35,100.00 x --
  • Ask 35,200.00 x --
  • Day's Range 34,200.00 - 35,650.00
  • 52 Week Range 34,200.00 - 55,600.00
  • Volume 8,361
  • Avg. Volume 2,673
  • Market Cap (intraday) 167.81B
  • Beta (5Y Monthly) 0.52
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date (est.) --
  • Forward Dividend & Yield 1,400.00 (3.99%)
  • Ex-Dividend Date Mar 30, 2026
  • 1y Target Est --

Chong Kun Dang Holdings Corp. manufactures and distributes pharmaceutical products in South Korea and internationally. Chong Kun Dang Holdings Corp. was founded in 1941 and is based in Seoul, South Korea.

www.ckd-holdings.com/company/summary.do

35

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/4/2026, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

001630.KS
21.58%
KOSPI Composite Index (^KS11)
34.87%

1-Year Return

001630.KS
19.22%
KOSPI Composite Index (^KS11)
37.90%

3-Year Return

001630.KS
29.77%
KOSPI Composite Index (^KS11)
139.99%

5-Year Return

001630.KS
51.42%
KOSPI Composite Index (^KS11)
90.53%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q4 FY25
Revenue 235.99B
Earnings --
Profit Margin 0.00%

Q1

FY25

Q2

FY25

Q3

FY25

Q4

FY25

0
50B
100B
150B
200B
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.58%

  • Return on Assets (ttm)

    2.09%

  • Return on Equity (ttm)

    7.86%

  • Revenue (ttm)

    961.64B

  • Net Income Avi to Common (ttm)

    53.67B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    154.23B

  • Total Debt/Equity (mrq)

    64.56%

  • Levered Free Cash Flow (ttm)

    -1.73B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: